TFFP Stock Price, Chart, Stats & News
TFF Pharmaceuticals, Inc. (TFFP) does not currently pay a dividend.
TFFP chart
Fundamentals
Gross margin | 31.53% |
Operating margin | -2983.45% |
Pretax margin | -2894.68% |
Net margin | -2894.68% |
Effective tax rate | – |
ROA | -176.62% |
ROE | -130.94% |
D/E | 0.01x |
Interest coverage ratio | – |
TFFP valuation
P/E | – |
P/S | 0.39x |
P/B | 0.01x |
P/CF | -0.01x |
P/FCF | -0.02x |
P/OCF | -0.01x |
PEG | -0.00x |
EV multiple | -0.27x |
About
Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address various pulmonary ailments and disorders. Its two leading drug candidates, both currently in Phase II clinical trials, include TFF Voriconazole Inhalation Powder, designed to combat invasive pulmonary aspergillosis, and TFF Tacrolimus Inhalation Powder, aimed at preventing lung transplant rejection.
Similar securities
Based on sector and market capitalization
